Cristina Agulló

Mass spectrometry vs immunofixation for treatment monitoring in multiple myeloma

Noemí Puig, María-Teresa Contreras, Cristina Agulló et al. · Blood Advances · 2022 · 46 citations · Full text

Qip-Mass Spectrometry in High Risk Smoldering Multiple Myeloma Patients Included in the GEM-CESAR Trial: Comparison with Conventional and Minimal Residual Disease IMWG Response Assessment

Noemí Puig, María‐Victoria Mateos, Teresa Contreras et al. · Blood · 2019 · 21 citations

Assessment of Treatment Response By Ife, Next Generation Flow Cytometry and Mass Spectrometry Coupled with Liquid Chromatography in the GEM2012MENOS65 Clinical Trial

Noemí Puig, Teresa Contreras Sanfeliciano, Bruno Paiva et al. · Blood · 2021 · 12 citations

Minimally Invasive Assessment of Peripheral Residual Disease During Maintenance or Observation in Transplant-Eligible Patients With Multiple Myeloma

Marta Lasa, Laura Notarfranchi, Cristina Agulló et al. · Journal of Clinical Oncology · 2024 · 12 citations